BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25889236)

  • 21. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice.
    Hoyer BF; Moser K; Hauser AE; Peddinghaus A; Voigt C; Eilat D; Radbruch A; Hiepe F; Manz RA
    J Exp Med; 2004 Jun; 199(11):1577-84. PubMed ID: 15173206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development.
    Jang E; Jeong M; Kim S; Jang K; Kang BK; Lee DY; Bae SC; Kim KS; Youn J
    Cell Transplant; 2016; 25(1):1-15. PubMed ID: 25975931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal increase of neuronal precursor cells and exacerbated neuroinflammation in the corpus callosum in murine model of systemic lupus erythematosus.
    Leung JW; Lau BW; Chan VS; Lau CS; So KF
    Restor Neurol Neurosci; 2016 May; 34(3):443-53. PubMed ID: 27163251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-α induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZB×NZW)F1 mice but not in BALB/c mice.
    Mathian A; Gallegos M; Pascual V; Banchereau J; Koutouzov S
    Eur J Immunol; 2011 Mar; 41(3):863-72. PubMed ID: 21312191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subset size, activation threshold and distribution of autoreactive MZ and FO B cells do not differ in a sex-specific manner in the NZB/W F1 murine lupus model: an experimental mouse study.
    Enghard P; Grussie E; Rieder C; Burmester GR; Riemekasten G
    Lupus; 2011 Oct; 20(12):1240-9. PubMed ID: 21844114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leptin promotes lupus T-cell autoimmunity.
    Amarilyo G; Iikuni N; Shi FD; Liu A; Matarese G; La Cava A
    Clin Immunol; 2013 Dec; 149(3):530-3. PubMed ID: 24263282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
    Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
    Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cells in systemic lupus erythematosus: the long and short of it all.
    Liu Z; Zou Y; Davidson A
    Eur J Immunol; 2011 Mar; 41(3):588-91. PubMed ID: 21341259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells.
    Ichikawa HT; Conley T; Muchamuel T; Jiang J; Lee S; Owen T; Barnard J; Nevarez S; Goldman BI; Kirk CJ; Looney RJ; Anolik JH
    Arthritis Rheum; 2012 Feb; 64(2):493-503. PubMed ID: 21905015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered bone marrow cell sensitivity in the lupus-prone NZB/W mouse: regulation of CFU-GM colony formation by estrogen, tamoxifen and thrombopoietin.
    Aronica SM; Dozier A; Fanti P; Nazareth M
    Lupus; 2000; 9(4):271-7. PubMed ID: 10866098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-selectin-specific autoantibodies in murine lupus: possible involvement in abnormal homing and polarization of CD4+ T cell subsets.
    Hattori S; Nishimura H; Tsurui H; Kato M; Endo N; Abe M; Akakura S; Mitsui K; Ishikawa S; Hirose S; Shirai T
    J Immunol; 1998 Aug; 161(3):1231-8. PubMed ID: 9686583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.
    Szalai AJ; Weaver CT; McCrory MA; van Ginkel FW; Reiman RM; Kearney JF; Marion TN; Volanakis JE
    Arthritis Rheum; 2003 Jun; 48(6):1602-11. PubMed ID: 12794828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local renal autoantibody production in lupus nephritis.
    Espeli M; Bökers S; Giannico G; Dickinson HA; Bardsley V; Fogo AB; Smith KG
    J Am Soc Nephrol; 2011 Feb; 22(2):296-305. PubMed ID: 21088295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
    Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small Molecule Inhibitors of Nuclear Export and the Amelioration of Lupus by Modulation of Plasma Cell Generation and Survival.
    Rangel-Moreno J; Garcia-Hernandez ML; Owen T; Barnard J; Becerril-Villanueva E; Kashyap T; Argueta C; Gamboa-Dominguez A; Tamir S; Landesman Y; Goldman BI; Ritchlin CT; Anolik JH
    Arthritis Rheumatol; 2022 Aug; 74(8):1363-1375. PubMed ID: 35333447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
    Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
    J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of SmD183-119-reactive T cells that provide T cell help for pathogenic anti-double-stranded DNA antibodies.
    Riemekasten G; Langnickel D; Ebling FM; Karpouzas G; Kalsi J; Herberth G; Tsao BP; Henklein P; Langer S; Burmester GR; Radbruch A; Hiepe F; Hahn BH
    Arthritis Rheum; 2003 Feb; 48(2):475-85. PubMed ID: 12571858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted silencing of DNA-specific B cells combined with partial plasma cell depletion displays additive effects on delaying disease onset in lupus-prone mice.
    Nikolova-Ganeva KA; Gesheva VV; Todorov TA; Voll RE; Vassilev TL
    Clin Exp Immunol; 2013 Nov; 174(2):221-8. PubMed ID: 23808414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.